CD276 and neoplasm: While I3A enhanced B7-H3-CAR T cell cytotoxicity at all T cell-to-target cell ratios evaluated, the difference was most pronounced at the lowest ratio tested (1 T cell to 8 tumor cells; Fig. 5c and Fig. S12a,b).